A phase I pilot trial to study the safety and efficacy of concomitant radiotherapy and zoledronic acid for the palliation of bone metastases from breast cancer, prostate cancer and lung cancer

Trial Profile

A phase I pilot trial to study the safety and efficacy of concomitant radiotherapy and zoledronic acid for the palliation of bone metastases from breast cancer, prostate cancer and lung cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Dec 2010

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Breast cancer; Cancer metastases; Lung cancer; Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Dec 2010 Trial phase changed from II to I and actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
    • 20 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top